8-K
filed September 28, 2022, 7:59 PM ET
ticker VICP
CIK 0001468639
leadership
confidence high
sentiment neutral
materiality 0.55
Vicapsys Life Sciences: Potts and Yurkowsky resign; Farrahar, Delaney, Rosenblum join board
Vicapsys Life Sciences, Inc.
- Board accepted resignations of directors John Potts and Michael Yurkowsky effective September 22, 2022; no disagreement.
- Appointed Charles 'Charlie' Farrahar (CPA, former CFO of several biotechs) as director.
- Appointed Dr. Colleen Delaney, stem cell transplant physician and CSO of Deverra Therapeutics, as director.
- Appointed Richard Rosenblum, President/CFO of Payment Solutions Inc. and CEO of Harborview Capital Advisors, as director.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Richard Rosenblum was appointed as director at Vicapsys Life Sciences, Inc..
- Action
- appointed
- Role
- director
Exact text from the filing
appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
John Potts resigned as director at Vicapsys Life Sciences, Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
accepted the resignations of John Potts and Michael Yurkowsky as members of the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Yurkowsky resigned as director at Vicapsys Life Sciences, Inc..
- Action
- resigned
- Role
- director
Exact text from the filing
accepted the resignations of John Potts and Michael Yurkowsky as members of the Board, effective immediately.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Colleen Delaney was appointed as director at Vicapsys Life Sciences, Inc..
- Action
- appointed
- Role
- director
Exact text from the filing
appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Farrahar was appointed as director at Vicapsys Life Sciences, Inc..
- Action
- appointed
- Role
- director
Exact text from the filing
appointed each of Charles “Charlie” Farrahar, Dr. Colleen Delaney and Richard Rosenblum as members of the Board.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.